US2019192612A1PendingUtilityA1
Honey composition with l-alanyl-l-glutamine
Est. expiryMay 18, 2031(~4.8 yrs left)· nominal 20-yr term from priority
Inventors:Mike Mcinnes
A61P 43/00A61P 25/20A61P 25/00A61P 11/00A61K 38/05A61K 35/644A61K 35/64
28
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to compositions including honey and L-alanyl-L-glutamine, pharmaceutical compositions thereof, and a combined product comprising honey and L-alanyl-L-glutamine for a simultaneous, separate, or sequential use in therapy. The composition, pharmaceutical composition, and combined product have particular utility in improving sleep and treating sleep disorders such as insomnia or sleep apnoea.
Claims
exact text as granted — not AI-modifiedWhat is claimed:
1 . A composition comprising honey and L-alanyl-L-glutamine or pharmaceutically acceptable salts thereof.
2 . The composition of claim 1 , wherein the composition comprises 1% to 10% L-alanyl-L-glutamine by weight of the composition
3 . The composition of claim 1 , wherein the composition comprises an effective amount of L-alanyl-L-glutamine that is 10% or less by weight of the composition.
4 . The composition of claim 1 , further comprising a solvent.
5 . The composition of claim 1 , further comprising water.
6 . The composition of claim 1 , further comprising one or more pharmaceutically acceptable diluents, excipients, or carriers.
7 . A method for treating a sleep disorder by administering to a subject suffering from said sleep disorder the composition of claim 1 .
8 . The method of claim 5 , wherein the sleep disorder is insomnia.
9 . The method of claim 5 , wherein the sleep disorder is sleep apnoea.
10 . A method of improving sleep comprising administering to a subject in need thereof the composition of claim 1 .
11 . The method of claim 10 , comprising the step of administering the composition to the subject within 30 minutes prior to sleep.
12 . A combined product comprising honey and L-alanyl-L-glutamine or pharmaceutically acceptable salts thereof for simultaneous, separate, or sequential administration.
13 . The composition of claim 12 , wherein the composition comprises 1% to 10% L-alanyl-L-glutamine by weight of the combined product.
14 . The combined product of claim 12 , wherein the composition consists essentially of honey and L-alanyl-L-glutamine.
15 . The composition of claim 12 , further comprising water.
16 . A method for treating a sleep disorder by administering to a subject suffering from said sleep disorder the composition of claim 12 .
17 . The method of claim 16 , wherein the sleep disorder is insomnia.
18 . The method of claim 16 , wherein the sleep disorder is sleep apnoea.
19 . A method of improving sleep comprising administering to a subject in need thereof the composition of claim 12 .
20 . The method of claim 19 , comprising the step of administering the composition to the subject within 30 minutes prior to sleep.Join the waitlist — get patent alerts
Track US2019192612A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.